Fierce Drug Safety Week 2021 has ended
avatar for Jason Ancell

Jason Ancell

Associate Director, Global Risk Management Strategy, REMS Development, Implementation & Operations
Jason Ancell is Associate Director, Global Risk Management for Bristol Myers Squibb (BMS).  In his current role, Jason provides risk management support for BMS’s immunomodulatory drug class, including U.S. REMS.  Jason has over twelve years’ U.S. REMS experience; ranging from REMS administration, healthcare consulting, and generic & branded REMS sponsors.  He holds an MBA from Southern New Hampshire University and a PMP® certification from the Project Management Institute.  

My Speakers Sessions

Tuesday, January 19

10:40am EST

Wednesday, January 20

11:15am EST